UKUK

GSK and HGS get approval for lupus drug

15.07.2011

London/Rockville - GlaxoSmithKline and its American partner Human Genome Sciences, Inc. announced today that the European Commission has granted marketing authorisation for belimumab (Benlysta) as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus, with a high degree of disease activity (e.g. positive anti-dsDNA and low complement), despite standard therapy. "We and GSK are committed to making Benlysta available in countries worldwide," said H. Thomas Watkins, President and Chief Executive Officer, HGS. "We are particularly honoured to be bringing this medicine forward in Europe, where a number of key academic research institutions were very important to its clinical development." Belimumab received approval from the U.S. FDA on March 9, 2011. GSK and HGS announced approval from Health Canada on July 12, 2011. Regulatory applications have been submitted and are currently under review in Australia, Switzerland, Russia, Brazil, The Philippines, Israel, Singapore, Taiwan and Colombia. HGS and GSK have been working together on belimumab since 2006. Under the agreement, HGS had responsibility for conducting the belimumab Phase 3 trials, with assistance from GSK. The companies share equally in Phase 3/4 development costs, sales and marketing expenses, and profits of any product commercialised under the current agreement.

UKUK

22.11.2007

London – The London and the Tokyo Stock Exchanges have announced a new AIM-like market for small and emerging Asian companies. Based in Tokyo, the market – slated for launch by the end of next year – will be a joint venture on an...

UKUK

17.10.2007

London – British scientists could create the country’s first interspecies embryos by the end of the year, after the Government’s fertility watchdog approved the work in principle. Two teams seeking to fuse human DNA with empty...

UKUK

24.09.2007

London – The UK has established the National Industrial Biotechnology Facility in Wilton as a testbed for developing cleaner and more sustainable biotech-based processes to replace traditional methods for manufacturing chemicals....

UKUK

24.09.2007

Manchester – John Hutchinson, a key figure at Vernalis, one of Britain’s bestknown biotech companies, resigned at the beginning of September to take up a new job at Renovo. The Manchester University spin-out is currently one of...

UKUK

24.09.2007

London/New York – Individualised medicines are getting ever closer. At the end of August, the US Food and Drug Administration, FDA, added information to the label of BristolMyers-Squibb’s Warfarin about how different genotypes...

BioPeople, UKUK

24.09.2007

Silence Therapeutics plc (London, UK) has strengthened its core management team with Jeffery Scott Vick (45) as Group CEO. Vick began his career as business analyst and biotech venture capitalist and then worked in senior...

UKUK

11.07.2007

London – Researchers at the University of Manchester have identified evidence of several new genes behind the chronic inflammatory disease rheumatoid arthritis (RA). Prof. Jane Worthington and her team at the University’s...

UKUK

11.07.2007

London – Europe should weigh the benefits as well as the risks when evaluating new farm technologies that may be the key to future food security, an advisory report for the UK government has recommended. The ACRE (Advisory...

UK, Tech ReviewUK

11.07.2007

AstraZeneca has been one of the most active pharma companies in terms of buying biotech firms. Just this year, the Anglo-Swedish pharma giant spent US$150 million on anti-infective specialist Arrow Therapeutics and took over the...

UKUK

11.07.2007

London – Urgent action is needed to tackle antibiotic resistance, or more people will die from what were previously treatable infections. This is the message of the new report ‘Tackling antibacterial resistance in Europe’ by the...

Displaying results 201 to 210 out of 396

< Previous 201-210 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-uk/browse/20/article/gsk-and-hgs-get-approval-for-lupus-drug.html

Product of the week

Products

Events

All Events

Current issue

All issues